Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities
@article{Prens2013NonablativeFR, title={Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities}, author={Sebastiaan P Prens and Karin de Vries and Hendrik Arent Martino Neumann and Errol P. Prens}, journal={Journal of Dermatological Treatment}, year={2013}, volume={24}, pages={227 - 231} }
Background: Actinic keratoses (AK) are premalignant lesions occurring mainly in sun-damaged skin. Current topical treatment options for AK and photo-damaged skin such as liquid nitrogen and electrosurgery are not suitable for field treatment. Otherwise, therapies suitable for field treatment bring along considerable patient discomfort. Non-ablative fractional resurfacing has emerged as a logical treatment option especially for field treatment of AK. Objectives: To evaluate the clinical efficacy…
14 Citations
Laser Resurfacing Monotherapy for the Treatment of Actinic Keratosis
- MedicineJournal of cutaneous medicine and surgery
- 2021
Despite longer healing time, fully ablative laser resurfacing, including carbon dioxide and erbium-doped yttrium aluminum garnet were found to be more effective for AK treatment than fractional ablative techniques.
Laser treatment and its implications for photodamaged skin and actinic keratosis.
- MedicineCurrent problems in dermatology
- 2015
Laser resurfacing has a place in the (field) treatment of widespread AKs and extensive photodamage, and both ablative laser resurfacing and fractional laser treatments are effective in reducing AKs.
Another approach to actinic keratosis management using nonablative fractional laser
- MedicineThe Journal of dermatological treatment
- 2014
The authors review data that lead dermatologists to focus efforts on treatment of actinic keratoses as one method of secondary prevention of non-melanoma skin cancer and suggest that routine sunprotection may be cost effective and useful in driving public debate over health care expenditures.
Current therapies for actinic keratosis
- MedicineInternational journal of dermatology
- 2020
Different types of available treatments ofActinic keratosis are shown and the characteristics and benefits of each medication are described, underlining the best choice.
Therapies for actinic keratosis with a focus on cosmetic outcomes.
- MedicineCutis
- 2015
The efficacy of the most commonly utilized treatments for AKs are reviewed including topical medications, procedural modalities, and light-based therapies, and the relevant cosmetic considerations and outcomes are discussed.
Intensified fractional CO2 laser‐assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart‐like lesions: a randomized half‐side comparative trial on dorsal hands
- MedicineThe British journal of dermatology
- 2013
Photodynamic therapy (PDT) is a well‐documented treatment for actinic keratosis (AK), but achieves inferior efficacy in organ transplant recipients (OTRs), particularly in acral regions. Ablative…
The Use of Lasers (Ablative Laser, Non-ablative Laser, Fractional Laser, Photobiomodulation (PBM)) in Skin Regeneration
- MedicineInternational Journal of Biological, Physical and Chemical Studies
- 2022
PBM technology was used without thermal interactions and effects on the skin, increasing patient satisfaction with rejuvenation, and according to research, these three lasers produce unfavorable outcomes.
Management of actinic keratosis: a practical report and treatment algorithm from AKTeamTM expert clinicians
- MedicineJournal of the European Academy of Dermatology and Venereology : JEADV
- 2014
National and international guidelines have been published, however, they are based on clinical trials with highly selected patient populations and do not always capture the range of patients seen in everyday practice.
Topical therapies for skin cancer and actinic keratosis.
- MedicineEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- 2015
British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017
- MedicineThe British journal of dermatology
- 2017
British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017 D. de Berker, J.M. McGregor, M.F. Mohd Mustapa, L.S. Exton and B.R. Hughes Bristol Dermatology…
References
SHOWING 1-10 OF 21 REFERENCES
Fractional Photothermolysis: Treatment of Facial and Nonfacial Cutaneous Photodamage with a 1,550‐nm Erbium‐Doped Fiber Laser
- MedicineDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
- 2007
The nonablative 1,550 nm erbium-doped fiber laser is an effective treatment for facial and non-facial photodamage, rhytides, and dyspigmentation with a favorable recovery and side effect profile.
Fractional Photothermolysis: A Novel Aesthetic Laser Surgery Modality
- MedicineDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
- 2007
Light is shed on the technical aspects, biologic mechanisms, and clinical effects of fractional photothermolysis that help set it apart from previous modes of laser surgery.
The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing.
- MedicineJournal of the American Academy of Dermatology
- 2008
Fractional photothermolysis: Current and future applications
- MedicineLasers in surgery and medicine
- 2006
Fractional photothermolysis (FP) produces arrays of microscopic thermal wounds called microscopic treatment zones (MTZs) at specific depths in the skin without injuring surrounding tissue and represents an alternative for treatment of dermatologic conditions without the adverse effects of ablative laser devices.
Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
- MedicineJournal of drugs in dermatology : JDD
- 2008
The sequential treatment with cryosurgery followed by diclofenac sodium 3% gel for 90 days is well tolerated and can provide a therapeutic modality that may provide patients with actinic keratoses a more successful outcome than monotherapy with cryOSurgery by effectively treating clinical and subclinical lesions.
Review of photodynamic therapy in actinic keratosis and basal cell carcinoma
- MedicineTherapeutics and clinical risk management
- 2008
This review covers the fundamental aspects of topical PDT and its application for treatment of actinic keratosis and basal cell carcinoma and both potentials and limitations will be reviewed, as well as some recent development within the field.
Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
- MedicineJournal of drugs in dermatology : JDD
- 2007
Five percent 5-FU was more effective than imiquimod in exposing what were presumed to be subclinical AKs, reducing the final AK count and achieving complete clearance rapidly, and tolerance was similar except for erythema.
Photodynamic Therapy in the Treatment of Actinic Keratosis †
- MedicinePhotochemistry and photobiology
- 2008
The efficacy and the low risk of side effects of PDT have resulted in a high patient preference in clinical trials and the value of PDT in comparison with cryotherapy or 5‐fluorouracil is discussed.
Long-term treatment of photoaged human skin with topical retinoic acid improves epidermal cell atypia and thickens the collagen band in papillary dermis.
- MedicineJournal of the American Academy of Dermatology
- 2005
A randomised study of topical 5% imiquimod vs. topical 5‐fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1‐year follow‐up
- MedicineThe British journal of dermatology
- 2007
Background Actinic keratoses (AK) frequently occur on sun‐exposed skin and are considered as in situ squamous cell carcinoma. To date, no treatment algorithm exists for first or second line…